Revolution Medicines stock rises on Merck acquisition talks

January 9, 2026

Revolution Medicines stock rises on Merck acquisition talks

Breaking News

Image source: Adobe Stock



Revolution Medicines stock closed 5% higher Thursday and added another 15% in after-hours trading following a Financial Times report that Merck is in talks to acquire the biotech company.

According to the report, citing people familiar with the matter, Merck has been pursuing an acquisition of the Redwood City–based biotech firm, though a deal has not been finalized.

Any potential agreement would be at least several weeks away, sources said.

A price range of $28 billion to $32 billion was being discussed as part of the negotiations, one of the people added. Yahoo Finance reports.

EdgeUp

🌐 Dow, S&P 500, Nasdaq futures mark time ahead of key jobs report, Supreme Court tariff decision

US stock futures were largely unchanged on Friday as investors braced for the pivotal monthly jobs report and a possible Supreme Court ruling on President Trump’s “Liberation Day” tariffs.

Futures tied to the Dow Jones Industrial Average, the S&P 500, and the Nasdaq 100 were little changed after closing mixed on Thursday, as appetite for technology stocks faded.

Markets are focused on two potential catalysts: the December jobs report and the possibility of a Supreme Court decision on the legality of Trump’s sweeping tariffs. Yahoo Finance reports.


💊 AbbVie stock drops after Revolution deal denial as $1.3 billion charge spooks traders

AbbVie shares fell Thursday after the drugmaker denied takeover talks with Revolution Medicines and flagged a $1.3 billion fourth-quarter charge that is expected to dent its 2025 profit outlook.

The stock was down 3.7% at $224.84 early afternoon, after swinging between $231.93 and $223.84.

The decline took steam out of a rally sparked by a Wall Street Journal report that AbbVie was in advanced talks to buy Revolution Medicines.

AbbVie told Reuters it “is not in discussions with Revolution Medicines,” and also trimmed its 2025 profit forecast after flagging the $1.3 billion charge. TechStock² reports.


⛏️ Rio Tinto and Glencore in talks to form world’s biggest miner

Rio Tinto Group is in talks to buy Glencore to create the world’s biggest mining company with a combined market value of more than $200 billion, a little over a year after earlier talks between the two collapsed.

The companies have been discussing a potential combination of some or all of their businesses, including an all-share takeover, they said in separate statements Thursday.

Glencore shares surged 10% in London, while Rio Tinto retreated 2.2% after falling 6.3% in Australia. Yahoo Finance reports.


🛒 Costco stock jumps after December sales climb — what matters before Friday’s open

The monthly report matters because it lands between earnings and can quickly reset expectations for traffic, pricing and renewal-driven demand.

Costco’s numbers are also watched as a bellwether for big-box retailers including Walmart and Target, and for warehouse rival BJ’s Wholesale Club.

The move shows how tightly investors are trading the story right now. Costco has been priced for steady growth, so any sign that sales are bending — up or down — can swing the stock hard. TechStock² reports.


💾 Seagate stock tumbles nearly 8% as AI-storage trade cools ahead of payrolls

Seagate Technology Holdings plc shares fell 7.7% to close at $284.47 on Thursday, giving back more of this week’s sharp run-up in the data-storage group.

The drop came as investors stepped away from “AI-linked” memory and storage winners after a strong start to the year.

SanDisk fell 5.4% and Western Digital dropped 6.1% as the broader Nasdaq slipped and the S&P 500’s tech index lagged. Macro nerves were in the mix. TechStock² reports.


👑 Why Alphabet’s stock can further reign as ‘king’ of the AI trade in 2026

Alphabet’s artificial-intelligence capabilities have made the company a formidable name in the technology landscape, powering the stock to a 65% gain in 2025.

That momentum could continue, as Wall Street firm Cantor Fitzgerald sees more room to run for the Google parent.

In a Wednesday note, analyst Deepak Mathivanan upgraded Alphabet to overweight from neutral with a price target of $370, calling the company the “king of all AI trades.” MarketWatch reports.


🏭 TSMC fourth-quarter revenue jumps 20%, beats forecasts

TSMC, the world’s largest contract chipmaker, reported a 20.45% increase in fourth-quarter revenue from a year earlier, beating market forecasts, as demand surged in response to growing interest in artificial intelligence applications.

The company, whose customers include Nvidia and Apple, has been a major beneficiary of advances in AI, which have more than offset the tapering of pandemic-led demand for chips used in consumer electronics such as tablets. Reuters reports.

Top 5 Movers in Early Pre-Market

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM Eastern Time)
Stock Analysis reports.


1) CETX: Cemtrex, Inc.
Total gain: +27.24%

2) ANPA: Rich Sparkle Holdings Limited
Total gain: +19.92%

3) OKLO: Oklo Inc.
Total gain: +19.61%

4) KALV: KalVista Pharmaceuticals, Inc.
Total gain: +15.49%

5) RVMD: Revolution Medicines, Inc.
Total gain: +14.84%

Yesterday’s Biggest Movers

The closing price of the top three market percent gainers trading near or above $3 on January 8.
Stock Analysis reports.

*All pricing and percent gains are based on regular market trading hours from 9:30am to 4:00pm Eastern Time

1) FLYX: flyExclusive, Inc.
Total gain: +130.25%
The company announced that it is commencing an underwritten public offering of shares of its common stock (or common stock equivalents). The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Businesswire reports.

2) ELVN: Enliven Therapeutics, Inc.
Total gain: +50.29%
The company announced positive initial data from the ongoing Phase 1b ENABLE clinical trial evaluating ELVN-001 in patients with chronic myeloid leukemia (CML) that is relapsed, refractory or intolerant to available tyrosine kinase inhibitors (TKIs). PR Newswire reports.

3) ACON: Aclarion, Inc.
Total gain: +42.09%
The stock appeared to be moving on no notable news.

Today’s Economic Dates

Time (ET)/ Report/ Period

8:30 AM - U.S. employment report - Dec.
8:30 AM - U.S. unemployment rate - Dec.
8:30 AM - U.S. hourly wages - Dec.

Parting Thoughts

“In speculation, patience matters more than intelligence.”

– Masajirō Tazuke

Sourced in: Masajirō Tazuke Biography – Japanese Speculators.

Disclaimer

TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).

TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference. There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses. Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.

If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.